Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia, Armenia, and South Africa and in a multicountry st...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbuagbaw, Lawrence, Guglielmetti, Lorenzo, Hewison, Catherine, Bakare, Nyasha, Bastard, Mathieu, Caumes, Eric, Fréchet-Jachym, Mathilde, Robert, Jérôme, Veziris, Nicolas, Khachatryan, Naira, Kotrikadze, Tinatin, Hayrapetyan, Armen, Avaliani, Zaza, Schünemann, Holger J., Lienhardt, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478224/
https://www.ncbi.nlm.nih.gov/pubmed/31002070
http://dx.doi.org/10.3201/eid2505.181823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478224/
https://www.ncbi.nlm.nih.gov/pubmed/31002070
http://dx.doi.org/10.3201/eid2505.181823

Ejemplares similares